GO:0005829 | cytosol | 6.07e-06 | 8.76e-02 | 2.361 | 8 | 132 | 2496 |
GO:0005838 | proteasome regulatory particle | 2.28e-05 | 3.28e-01 | 8.061 | 2 | 7 | 12 |
GO:0022624 | proteasome accessory complex | 4.68e-05 | 6.76e-01 | 7.559 | 2 | 8 | 17 |
GO:0044281 | small molecule metabolic process | 3.91e-04 | 1.00e+00 | 2.726 | 5 | 58 | 1211 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.17e-04 | 1.00e+00 | 6.002 | 2 | 17 | 50 |
GO:0010467 | gene expression | 4.79e-04 | 1.00e+00 | 3.260 | 4 | 59 | 669 |
GO:0000502 | proteasome complex | 5.62e-04 | 1.00e+00 | 5.788 | 2 | 17 | 58 |
GO:0004512 | inositol-3-phosphate synthase activity | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0019521 | D-gluconate metabolic process | 6.24e-04 | 1.00e+00 | 10.646 | 1 | 1 | 1 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 6.84e-04 | 1.00e+00 | 5.646 | 2 | 19 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 7.05e-04 | 1.00e+00 | 5.624 | 2 | 22 | 65 |
GO:0019901 | protein kinase binding | 8.01e-04 | 1.00e+00 | 3.923 | 3 | 21 | 317 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 8.18e-04 | 1.00e+00 | 5.517 | 2 | 22 | 70 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 8.65e-04 | 1.00e+00 | 5.476 | 2 | 20 | 72 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 9.13e-04 | 1.00e+00 | 5.437 | 2 | 22 | 74 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 9.38e-04 | 1.00e+00 | 5.417 | 2 | 20 | 75 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 1.04e-03 | 1.00e+00 | 5.342 | 2 | 23 | 79 |
GO:0070062 | extracellular vesicular exosome | 1.12e-03 | 1.00e+00 | 2.002 | 6 | 104 | 2400 |
GO:0051538 | 3 iron, 4 sulfur cluster binding | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0019322 | pentose biosynthetic process | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 2 | 2 |
GO:0003994 | aconitate hydratase activity | 1.25e-03 | 1.00e+00 | 9.646 | 1 | 1 | 2 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.41e-03 | 1.00e+00 | 5.123 | 2 | 21 | 92 |
GO:0016020 | membrane | 1.80e-03 | 1.00e+00 | 2.253 | 5 | 90 | 1681 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:1900126 | negative regulation of hyaluronan biosynthetic process | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 |
GO:0006021 | inositol biosynthetic process | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0009051 | pentose-phosphate shunt, oxidative branch | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 |
GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 1 | 3 |
GO:0071439 | clathrin complex | 1.87e-03 | 1.00e+00 | 9.061 | 1 | 2 | 3 |
GO:0030529 | ribonucleoprotein complex | 2.08e-03 | 1.00e+00 | 4.839 | 2 | 8 | 112 |
GO:0000209 | protein polyubiquitination | 2.23e-03 | 1.00e+00 | 4.788 | 2 | 20 | 116 |
GO:0032051 | clathrin light chain binding | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:1903077 | negative regulation of protein localization to plasma membrane | 2.49e-03 | 1.00e+00 | 8.646 | 1 | 1 | 4 |
GO:0044267 | cellular protein metabolic process | 2.56e-03 | 1.00e+00 | 3.342 | 3 | 29 | 474 |
GO:0043248 | proteasome assembly | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0006102 | isocitrate metabolic process | 3.12e-03 | 1.00e+00 | 8.324 | 1 | 1 | 5 |
GO:0061024 | membrane organization | 3.45e-03 | 1.00e+00 | 4.466 | 2 | 7 | 145 |
GO:0000082 | G1/S transition of mitotic cell cycle | 3.64e-03 | 1.00e+00 | 4.427 | 2 | 32 | 149 |
GO:0042981 | regulation of apoptotic process | 3.69e-03 | 1.00e+00 | 4.417 | 2 | 24 | 150 |
GO:0030130 | clathrin coat of trans-Golgi network vesicle | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0030957 | Tat protein binding | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 3 | 6 |
GO:0006101 | citrate metabolic process | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 1 | 6 |
GO:0030118 | clathrin coat | 3.74e-03 | 1.00e+00 | 8.061 | 1 | 2 | 6 |
GO:0030132 | clathrin coat of coated pit | 4.36e-03 | 1.00e+00 | 7.839 | 1 | 2 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.76e-03 | 1.00e+00 | 4.228 | 2 | 20 | 171 |
GO:0070688 | MLL5-L complex | 4.98e-03 | 1.00e+00 | 7.646 | 1 | 1 | 8 |
GO:0008494 | translation activator activity | 5.60e-03 | 1.00e+00 | 7.476 | 1 | 1 | 9 |
GO:0006098 | pentose-phosphate shunt | 6.22e-03 | 1.00e+00 | 7.324 | 1 | 4 | 10 |
GO:0016071 | mRNA metabolic process | 7.98e-03 | 1.00e+00 | 3.845 | 2 | 31 | 223 |
GO:0008654 | phospholipid biosynthetic process | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 3 | 13 |
GO:0006412 | translation | 8.47e-03 | 1.00e+00 | 3.801 | 2 | 20 | 230 |
GO:0035267 | NuA4 histone acetyltransferase complex | 8.70e-03 | 1.00e+00 | 6.839 | 1 | 4 | 14 |
GO:0016070 | RNA metabolic process | 9.71e-03 | 1.00e+00 | 3.698 | 2 | 32 | 247 |
GO:0050998 | nitric-oxide synthase binding | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 1 | 16 |
GO:0042176 | regulation of protein catabolic process | 9.94e-03 | 1.00e+00 | 6.646 | 1 | 3 | 16 |
GO:0003746 | translation elongation factor activity | 1.06e-02 | 1.00e+00 | 6.559 | 1 | 3 | 17 |
GO:0048863 | stem cell differentiation | 1.18e-02 | 1.00e+00 | 6.398 | 1 | 1 | 19 |
GO:0030863 | cortical cytoskeleton | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.36e-02 | 1.00e+00 | 6.187 | 1 | 4 | 22 |
GO:0043234 | protein complex | 1.37e-02 | 1.00e+00 | 3.442 | 2 | 18 | 295 |
GO:0043044 | ATP-dependent chromatin remodeling | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 4 | 23 |
GO:0005844 | polysome | 1.43e-02 | 1.00e+00 | 6.123 | 1 | 4 | 23 |
GO:0008135 | translation factor activity, nucleic acid binding | 1.49e-02 | 1.00e+00 | 6.061 | 1 | 7 | 24 |
GO:0050661 | NADP binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 2 | 27 |
GO:0031492 | nucleosomal DNA binding | 1.67e-02 | 1.00e+00 | 5.891 | 1 | 4 | 27 |
GO:0006099 | tricarboxylic acid cycle | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 28 |
GO:0030669 | clathrin-coated endocytic vesicle membrane | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 4 | 28 |
GO:0019894 | kinesin binding | 1.73e-02 | 1.00e+00 | 5.839 | 1 | 1 | 28 |
GO:0033572 | transferrin transport | 1.86e-02 | 1.00e+00 | 5.739 | 1 | 5 | 30 |
GO:0031623 | receptor internalization | 1.92e-02 | 1.00e+00 | 5.692 | 1 | 2 | 31 |
GO:0005925 | focal adhesion | 2.05e-02 | 1.00e+00 | 3.130 | 2 | 19 | 366 |
GO:0032588 | trans-Golgi network membrane | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 2 | 34 |
GO:0001895 | retina homeostasis | 2.10e-02 | 1.00e+00 | 5.559 | 1 | 1 | 34 |
GO:0051539 | 4 iron, 4 sulfur cluster binding | 2.16e-02 | 1.00e+00 | 5.517 | 1 | 3 | 35 |
GO:0034332 | adherens junction organization | 2.22e-02 | 1.00e+00 | 5.476 | 1 | 1 | 36 |
GO:0051084 | 'de novo' posttranslational protein folding | 2.29e-02 | 1.00e+00 | 5.437 | 1 | 4 | 37 |
GO:0000278 | mitotic cell cycle | 2.33e-02 | 1.00e+00 | 3.035 | 2 | 48 | 391 |
GO:0044822 | poly(A) RNA binding | 2.35e-02 | 1.00e+00 | 2.187 | 3 | 49 | 1056 |
GO:0070527 | platelet aggregation | 2.35e-02 | 1.00e+00 | 5.398 | 1 | 2 | 38 |
GO:0043647 | inositol phosphate metabolic process | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 39 |
GO:0005654 | nucleoplasm | 2.51e-02 | 1.00e+00 | 2.152 | 3 | 76 | 1082 |
GO:0030136 | clathrin-coated vesicle | 2.59e-02 | 1.00e+00 | 5.254 | 1 | 4 | 42 |
GO:0006892 | post-Golgi vesicle-mediated transport | 2.65e-02 | 1.00e+00 | 5.220 | 1 | 3 | 43 |
GO:0021762 | substantia nigra development | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 2 | 44 |
GO:0045727 | positive regulation of translation | 2.71e-02 | 1.00e+00 | 5.187 | 1 | 3 | 44 |
GO:0043066 | negative regulation of apoptotic process | 2.71e-02 | 1.00e+00 | 2.918 | 2 | 31 | 424 |
GO:0003743 | translation initiation factor activity | 3.02e-02 | 1.00e+00 | 5.031 | 1 | 8 | 49 |
GO:0006091 | generation of precursor metabolites and energy | 3.08e-02 | 1.00e+00 | 5.002 | 1 | 3 | 50 |
GO:0003725 | double-stranded RNA binding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 5 | 52 |
GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding | 3.26e-02 | 1.00e+00 | 4.918 | 1 | 5 | 53 |
GO:0002244 | hematopoietic progenitor cell differentiation | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 1 | 54 |
GO:0045216 | cell-cell junction organization | 3.32e-02 | 1.00e+00 | 4.891 | 1 | 2 | 54 |
GO:0016032 | viral process | 4.14e-02 | 1.00e+00 | 2.585 | 2 | 55 | 534 |
GO:0034329 | cell junction assembly | 4.17e-02 | 1.00e+00 | 4.559 | 1 | 1 | 68 |
GO:0006915 | apoptotic process | 4.45e-02 | 1.00e+00 | 2.530 | 2 | 33 | 555 |
GO:0038096 | Fc-gamma receptor signaling pathway involved in phagocytosis | 4.53e-02 | 1.00e+00 | 4.437 | 1 | 6 | 74 |
GO:0008584 | male gonad development | 4.59e-02 | 1.00e+00 | 4.417 | 1 | 3 | 75 |
GO:0006898 | receptor-mediated endocytosis | 5.12e-02 | 1.00e+00 | 4.254 | 1 | 3 | 84 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 5.48e-02 | 1.00e+00 | 4.154 | 1 | 7 | 90 |
GO:0042470 | melanosome | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 9 | 91 |
GO:0006928 | cellular component movement | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 7 | 91 |
GO:0005200 | structural constituent of cytoskeleton | 5.54e-02 | 1.00e+00 | 4.138 | 1 | 8 | 91 |
GO:0001649 | osteoblast differentiation | 5.60e-02 | 1.00e+00 | 4.123 | 1 | 6 | 92 |
GO:0006414 | translational elongation | 5.66e-02 | 1.00e+00 | 4.107 | 1 | 13 | 93 |
GO:0014069 | postsynaptic density | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 3 | 105 |
GO:0005506 | iron ion binding | 6.37e-02 | 1.00e+00 | 3.932 | 1 | 4 | 105 |
GO:0072562 | blood microparticle | 6.72e-02 | 1.00e+00 | 3.852 | 1 | 3 | 111 |
GO:0005819 | spindle | 6.78e-02 | 1.00e+00 | 3.839 | 1 | 7 | 112 |
GO:0044237 | cellular metabolic process | 7.07e-02 | 1.00e+00 | 3.776 | 1 | 5 | 117 |
GO:0006325 | chromatin organization | 7.13e-02 | 1.00e+00 | 3.764 | 1 | 5 | 118 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 7.60e-02 | 1.00e+00 | 3.669 | 1 | 5 | 126 |
GO:0000790 | nuclear chromatin | 7.77e-02 | 1.00e+00 | 3.635 | 1 | 9 | 129 |
GO:0006413 | translational initiation | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 17 | 131 |
GO:0031982 | vesicle | 7.89e-02 | 1.00e+00 | 3.613 | 1 | 9 | 131 |
GO:0006457 | protein folding | 8.58e-02 | 1.00e+00 | 3.486 | 1 | 7 | 143 |
GO:0010628 | positive regulation of gene expression | 8.75e-02 | 1.00e+00 | 3.456 | 1 | 5 | 146 |
GO:0005198 | structural molecule activity | 8.98e-02 | 1.00e+00 | 3.417 | 1 | 5 | 150 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 9.84e-02 | 1.00e+00 | 3.280 | 1 | 7 | 165 |
GO:0030424 | axon | 9.90e-02 | 1.00e+00 | 3.271 | 1 | 4 | 166 |
GO:0006886 | intracellular protein transport | 1.02e-01 | 1.00e+00 | 3.228 | 1 | 5 | 171 |
GO:0003924 | GTPase activity | 1.16e-01 | 1.00e+00 | 3.024 | 1 | 12 | 197 |
GO:0001701 | in utero embryonic development | 1.19e-01 | 1.00e+00 | 2.995 | 1 | 8 | 201 |
GO:0005634 | nucleus | 1.20e-01 | 1.00e+00 | 0.814 | 5 | 136 | 4559 |
GO:0006184 | GTP catabolic process | 1.26e-01 | 1.00e+00 | 2.905 | 1 | 12 | 214 |
GO:0007067 | mitotic nuclear division | 1.33e-01 | 1.00e+00 | 2.820 | 1 | 14 | 227 |
GO:0005759 | mitochondrial matrix | 1.34e-01 | 1.00e+00 | 2.813 | 1 | 14 | 228 |
GO:0005975 | carbohydrate metabolic process | 1.47e-01 | 1.00e+00 | 2.663 | 1 | 9 | 253 |
GO:0005856 | cytoskeleton | 1.68e-01 | 1.00e+00 | 2.461 | 1 | 12 | 291 |
GO:0005525 | GTP binding | 1.78e-01 | 1.00e+00 | 2.370 | 1 | 12 | 310 |
GO:0007411 | axon guidance | 1.82e-01 | 1.00e+00 | 2.329 | 1 | 13 | 319 |
GO:0003723 | RNA binding | 1.94e-01 | 1.00e+00 | 2.228 | 1 | 20 | 342 |
GO:0055114 | oxidation-reduction process | 2.34e-01 | 1.00e+00 | 1.932 | 1 | 12 | 420 |
GO:0007596 | blood coagulation | 2.51e-01 | 1.00e+00 | 1.816 | 1 | 18 | 455 |
GO:0005515 | protein binding | 3.04e-01 | 1.00e+00 | 0.412 | 5 | 184 | 6024 |
GO:0045087 | innate immune response | 3.16e-01 | 1.00e+00 | 1.427 | 1 | 24 | 596 |
GO:0005615 | extracellular space | 4.61e-01 | 1.00e+00 | 0.744 | 1 | 17 | 957 |
GO:0005739 | mitochondrion | 4.76e-01 | 1.00e+00 | 0.683 | 1 | 28 | 998 |
GO:0005524 | ATP binding | 5.72e-01 | 1.00e+00 | 0.304 | 1 | 60 | 1298 |
GO:0046872 | metal ion binding | 5.75e-01 | 1.00e+00 | 0.294 | 1 | 25 | 1307 |
GO:0005730 | nucleolus | 6.63e-01 | 1.00e+00 | -0.034 | 1 | 69 | 1641 |
GO:0005737 | cytoplasm | 7.26e-01 | 1.00e+00 | -0.233 | 2 | 110 | 3767 |
GO:0005886 | plasma membrane | 8.31e-01 | 1.00e+00 | -0.688 | 1 | 45 | 2582 |